Neoadjuvant Immunotherapy Combined with Chemotherapy for Local Advanced Non-Small-Cell Lung Cancer in a Patient with a History of Breast Cancer: A Case Report

Neoadjuvant Immunotherapy Combined with Chemotherapy for Local Advanced Non-Small-Cell Lung Cancer in a Patient with a History of Breast Cancer: A Case Report

Durvalumab consolidation therapy is the standard treatment after concurrent chemoradiotherapy for patients with surgically unresectable stage IIIA (N2) non-small-cell lung cancer (NSCLC). Neoadjuvant therapy followed by surgery could reduce locoregional and distant recurrence and improve the surviva...

Full description

Bibliographic Details
Main Authors: Rui-Xia Yang, Yue Hei, Wen-Ting Zhu, Qian-Rong Wang, Hong-Mei Zhang, Yan Chen
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Current Oncology
Subjects:
Neoadjuvant immunotherapy
non-small-cell lung cancer
pathologic complete response
Online Access:https://www.mdpi.com/1718-7729/29/9/487

Internet

https://www.mdpi.com/1718-7729/29/9/487

Similar Items